The TBG (Thyroxine Binding Globulin) Test is a specialized blood test designed to measure the levels of TBG in the bloodstream. TBG is a crucial protein that plays a significant role in the transportation and regulation of thyroid hormones, such as thyroxine (T4) and triiodothyronine (T3), throughout the body. These hormones are vital for regulating metabolism, energy generation, and overall physical growth and development.
An imbalance in TBG levels can indicate various thyroid disorders or other health conditions, making this test an important diagnostic tool. High levels of TBG may suggest hypothyroidism, where the thyroid gland is underactive, while low levels could indicate hyperthyroidism, an overactive thyroid.
The TBG Thyroxine Binding Globulin Test is offered at DNA Labs UAE, a state-of-the-art facility known for its precision and reliability in diagnostic services. The test is priced at 1280 AED, reflecting the sophisticated techniques and equipment used to ensure accurate and timely results. Patients opting for this test at DNA Labs UAE can expect professional service and comprehensive support throughout the testing process, from sample collection to the interpretation of results.
The C-KIT Mutation Detection PCR Test is a highly specialized diagnostic procedure aimed at identifying mutations in the C-KIT gene. This gene is crucial because it provides instructions for making a protein that plays a key role in the growth and development of cells. Mutations in the C-KIT gene are associated with a variety of tumors, including gastrointestinal stromal tumors (GISTs), mastocytosis, and certain types of leukemia. Early detection of these mutations can significantly impact the treatment and management of these conditions.
The test utilizes Polymerase Chain Reaction (PCR) technology, a cutting-edge method that amplifies segments of DNA, making it possible to study the genetic material in great detail. This allows for the precise identification of mutations in the C-KIT gene.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the C-KIT Mutation Detection PCR Test is available for 1280 AED. DNA Labs UAE is known for its state-of-the-art technology and expertise in genetic diagnostics, ensuring accurate and reliable test results. This test is a valuable tool for clinicians in the diagnosis and management of diseases associated with C-KIT mutations, facilitating personalized treatment plans for affected individuals.
The Connexin 30 Mutation Detection Test is a specialized genetic test available at DNA Labs UAE, designed to identify mutations in the GJB6 gene, which encodes the connexin 30 protein. This protein plays a crucial role in the formation of gap junctions that facilitate direct cellular communication in various tissues, including the inner ear and skin. Mutations in the GJB6 gene can lead to a range of disorders, most notably hearing impairments and certain skin conditions.
The test is particularly relevant for individuals with a family history of hearing loss or those experiencing symptoms without a clear diagnosis. Early detection through this test can aid in the understanding of the condition's cause, enabling targeted interventions and informed decision-making regarding treatment options. It can also provide essential information for families considering future pregnancies.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing services, the Connexin 30 Mutation Detection Test is priced at 1260 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the GJB6 gene. Results from this test can offer valuable insights into the genetic basis of hearing loss and other related conditions, facilitating a personalized approach to healthcare.
The JAK2 Exon 12 Mutation Detection Test is a specialized diagnostic procedure designed to identify mutations within the exon 12 region of the Janus kinase 2 (JAK2) gene. This test is crucial for the diagnosis and management of certain myeloproliferative neoplasms (MPNs), which are a group of blood cancers characterized by the overproduction of blood cells. Mutations in the JAK2 gene, particularly in the exon 12 region, are associated with a subset of these disorders, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, especially in cases where the common JAK2 V617F mutation is not present.
Performed at DNA Labs UAE, a leading laboratory known for its advanced genetic testing capabilities, the JAK2 Exon 12 Mutation Detection Test utilizes state-of-the-art technology to provide accurate and reliable results. The test is recommended for individuals showing symptoms of MPNs or those with a known family history of these conditions, to assist in the diagnosis and to guide treatment strategies.
The cost of the JAK2 Exon 12 Mutation Detection Test at DNA Labs UAE is set at 1260 AED. Given the importance of this test in the accurate diagnosis and management of MPNs, it represents a valuable investment in one's health. Patients and healthcare providers can rely on DNA Labs UAE for precise diagnostics, thereby facilitating targeted and effective treatment plans for affected individuals.
The Lysozyme Muramidase Test is a specialized diagnostic procedure aimed at measuring the levels of lysozyme, an enzyme also known as muramidase, in the body. Lysozyme plays a crucial role in the immune system by breaking down the cell walls of certain bacteria, thus contributing to the body's defense against infections. Elevated or decreased levels of this enzyme can indicate various health conditions, including infections, inflammatory diseases, and certain types of leukemia.
The test involves a simple blood sample from the patient, which is then analyzed in a laboratory setting to determine the concentration of lysozyme present. Given its significance in diagnosing and monitoring various medical conditions, the Lysozyme Muramidase Test is an important tool in clinical diagnostics.
At DNA Labs UAE, this test is available for a cost of 1260 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable test results. The facility is committed to providing high-quality diagnostic services, making it a trusted choice for patients and healthcare providers seeking comprehensive health assessments.
The Pernicious Anemia Panel Test is a comprehensive diagnostic tool used to assess the presence of pernicious anemia, a type of vitamin B12 deficiency anemia caused by the body's inability to absorb vitamin B12 due to the lack of intrinsic factor. This condition can lead to various health issues, including fatigue, weakness, memory loss, and neurological changes. The test panel typically includes measurements of vitamin B12 levels, intrinsic factor antibodies, and other related markers to provide a thorough evaluation of the patient's condition.
At DNA Labs UAE, the Pernicious Anemia Panel Test is offered at a cost of 1260 AED. The facility ensures accurate and reliable results, utilizing advanced testing methodologies under the supervision of experienced professionals. This test is crucial for individuals experiencing symptoms of vitamin B12 deficiency or those at risk of pernicious anemia, enabling timely diagnosis and appropriate treatment to prevent complications.
The "5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response DPYD Variants Test" is a specialized diagnostic tool offered by DNA Labs UAE, priced at 1260 AED. This test is designed to identify genetic variants in the DPYD gene, which plays a crucial role in the metabolism of 5-FU, a common chemotherapeutic agent used in the treatment of various cancers, including colorectal, breast, and stomach cancers.
5-FU works by inhibiting DNA synthesis in cancer cells, thereby preventing their growth and proliferation. However, its effectiveness and the risk of toxicity vary significantly among individuals, largely due to genetic differences in the DPYD gene. Certain variants in the DPYD gene can lead to reduced or absent activity of the dihydropyrimidine dehydrogenase (DPD) enzyme, which is responsible for breaking down 5-FU. Individuals with these genetic variations may experience severe or life-threatening toxicity when treated with standard doses of 5-FU, including neutropenia, neurotoxicity, severe diarrhea, and mucositis.
The DPYD Variants Test aims to identify patients who are at an increased risk of experiencing adverse reactions to 5-FU chemotherapy. By analyzing specific genetic variants in the DPYD gene, healthcare providers can tailor chemotherapy treatments to the individual's genetic makeup, optimizing therapeutic outcomes while minimizing the risk of toxicity. This personalized approach to cancer treatment enhances the efficacy of 5-FU therapy and improves patient safety.
In summary, the 5-FU Toxicity and Chemotherapeutic Response DPYD Variants Test offered by DNA Labs UAE is a crucial tool in the field of personalized medicine, enabling clinicians to make informed decisions regarding 5-FU chemotherapy regimens based on a patient's genetic predisposition to drug toxicity. At a cost of 1260 AED, this test represents a valuable investment in optimizing cancer treatment and patient care.
The AML1-ETO AML - M2 Test is a specialized diagnostic procedure aimed at detecting the presence of the AML1-ETO fusion gene, which is commonly associated with Acute Myeloid Leukemia (AML), particularly the M2 subtype. This genetic anomaly results from a translocation between chromosomes 8 and 21, which plays a significant role in the pathogenesis of the disease. The test is crucial for the accurate diagnosis, prognosis, and determination of appropriate treatment strategies for patients suspected of having AML M2.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs sophisticated techniques to ensure precise and reliable results. The cost of the AML1-ETO AML - M2 Test is set at 1050 AED, reflecting the advanced technology and expertise required to conduct this complex analysis. By identifying the specific genetic alteration, this test enables healthcare providers to tailor treatment plans more effectively, potentially improving patient outcomes in those affected by this type of leukemia.
The BCL2 test is a specialized diagnostic procedure aimed at detecting the BCL2 gene rearrangements within cells. BCL2, short for B-cell lymphoma 2, is a gene implicated in various forms of cancer, most notably in lymphomas. Its protein product plays a crucial role in regulating cell death (apoptosis), and its overexpression can lead to an increased survival of cancer cells, contributing to the development and progression of the disease.
At DNA Labs UAE, this test is conducted with precision and care, leveraging advanced molecular techniques to provide accurate results. The test is crucial for patients suspected of having lymphomas or other related conditions, as it helps in confirming the diagnosis, guiding treatment decisions, and providing prognostic information. The cost of the BCL2 test at DNA Labs UAE is 1050 AED, reflecting the sophisticated nature of the testing and the invaluable insights it offers into the patient's health status. By identifying BCL2 gene rearrangements, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes.
The BCL6 test is a specialized diagnostic procedure designed to detect the presence and analyze the expression of the BCL6 gene. This gene plays a crucial role in the development and function of the immune system, and its abnormal expression is often associated with certain types of lymphoma, particularly diffuse large B-cell lymphoma (DLBCL). By assessing the BCL6 gene, healthcare professionals can gain valuable insights into the nature of lymphomas, aiding in accurate diagnosis and the formulation of effective treatment plans.
The test involves collecting a sample of tissue or blood from the patient, which is then analyzed in a laboratory setting to assess the BCL6 gene's status. This analysis can help determine the prognosis of lymphoma and guide therapeutic decisions, making it an essential tool in the management of patients with this type of cancer.
At DNA Labs UAE, the BCL6 test is available for 1050 AED. DNA Labs UAE is equipped with state-of-the-art facilities and employs cutting-edge technologies to ensure precise and reliable test results. The lab's team of expert professionals is committed to providing high-quality diagnostic services, ensuring that patients receive the most accurate information regarding their health condition.
